Data is not available at this time.
Kagome Co., Ltd. operates as a leading player in Japan's packaged foods sector, specializing in condiments, beverages, and health-focused products. The company's diversified portfolio includes soups, supplements, and vegetable-based offerings, leveraging its long-standing expertise in agricultural sourcing and food processing. Kagome maintains a vertically integrated model, controlling production from seed procurement to retail distribution, which enhances quality control and cost efficiency. Its strong brand recognition and heritage since 1899 position it as a trusted name in Japan's consumer defensive market. The company also engages in ancillary businesses like real estate and contract services, providing additional revenue streams. Kagome's focus on health-conscious products aligns with growing consumer demand for functional foods, reinforcing its competitive edge in a mature industry.
Kagome reported revenue of JPY 306.9 billion for FY2024, with net income of JPY 25.0 billion, reflecting a net margin of approximately 8.2%. Operating cash flow stood at JPY 31.7 billion, supported by disciplined cost management. Capital expenditures of JPY 10.9 billion indicate ongoing investments in production capabilities, though free cash flow remains positive, underscoring operational efficiency.
The company's diluted EPS of JPY 278.19 demonstrates solid earnings power, with a beta of 0.49 suggesting lower volatility relative to the market. Kagome's capital allocation balances reinvestment in core operations with stable profitability, though its debt-to-equity ratio warrants monitoring given total debt of JPY 72.7 billion.
Kagome holds JPY 21.3 billion in cash and equivalents against total debt of JPY 72.7 billion, indicating moderate liquidity. The balance sheet reflects a conservative leverage profile typical of consumer defensive firms, with sufficient coverage for near-term obligations. Its real estate holdings may provide additional financial flexibility.
Kagome's growth is driven by premiumization and health-focused product lines, though the mature domestic market limits rapid expansion. The dividend per share of JPY 48 reflects a commitment to shareholder returns, with a payout ratio aligned with industry peers. Future growth may hinge on international expansion or innovation in functional foods.
With a market cap of JPY 268.4 billion, Kagome trades at a P/E multiple reflective of its stable but slow-growth profile. The low beta suggests investor perception of resilience, though premium valuation depends on sustained margin improvement and niche market dominance.
Kagome's strengths include brand equity, vertical integration, and a focus on health trends. Challenges include demographic headwinds in Japan and input cost volatility. Strategic initiatives in R&D and supply chain optimization could enhance long-term competitiveness, while diversification into adjacent categories offers growth avenues.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |